Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 4

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 4
---
006 
  
    Issuance of common stock and warrants pursuant to January 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) 
     -  
     -  
     204,312  
     20  
     804,326  
     -  
     -  
     804,346  
     -  
     804,346 
  
    Issuance of common stock and warrants pursuant to February 2025 Offering, net of offering costs paid at closing and deferred offering costs (Note 6) 
     -  
     -  
     300,700  
     30  
     908,597  
     -  
     -  
     908,627  
     -  
     908,627 
  
    Issuance of common stock upon exercise of Pre-Funded Warrants 
     -  
     -  
     385,200  
     38  
     1,888  
     -  
     -  
     1,926  
     -  
     1,926 
  
    Issuance of shares for annual performance bonuses, net of shares withheld for taxes 
     -  
     -  
     15,809  
     2  
     103,542  
     -  
     -  
     103,544  
     -  
     103,544 
  
    Share-based compensation expense 
     -  
     -  
     -  
     -  
     142,645  
     -  
     -  
     142,645  
     -  
     142,645 
  
    Net foreign translation loss 
     -  
     -  
     -  
     -  
     -  
        
     (9,904) 
     (9,904) 
     -  
     (9,904)
  
    Net loss 
     -  
     -  
     -  
     -  
     -  
     (1,876,549) 
     -  
     (1,876